Lee HS - Search Results

1

Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma.

Kim W, Yoon JH, Jeong JM, Cheon GJ, Lee TS, Yang JI, Park SC, Lee HS. Kim W, et al. Among authors: lee hs, lee ts. Mol Cancer Ther. 2007 Sep;6(9):2554-62. doi: 10.1158/1535-7163.MCT-07-0115. Mol Cancer Ther. 2007. PMID: 17876052

2

Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth.

Park SC, Yoon JH, Lee JH, Yu SJ, Myung SJ, Kim W, Gwak GY, Lee SH, Lee SM, Jang JJ, Suh KS, Lee HS. Park SC, et al. Among authors: lee sh, lee hs, lee sm, lee jh. Cancer Lett. 2008 Nov 28;271(2):314-22. doi: 10.1016/j.canlet.2008.06.019. Epub 2008 Jul 25. Cancer Lett. 2008. PMID: 18657357

3

Enhanced interleukin-2 diphtheria toxin conjugate-induced growth suppression in retinoic acid-treated hypoxic hepatocellular carcinoma cells.

Kim BH, Yoon JH, Myung SJ, Lee JH, Lee SH, Lee SM, Lee HS. Kim BH, et al. Among authors: lee sh, lee hs, lee sm, lee jh. Cancer Lett. 2009 Feb 18;274(2):259-65. doi: 10.1016/j.canlet.2008.09.025. Epub 2008 Nov 4. Cancer Lett. 2009. PMID: 18986761

4

Experimental agents which inhibit hepatocarcinogenesis.

Yoon JH, Lee HS. Yoon JH, et al. Among authors: lee hs. Oncology. 2008;75 Suppl 1:17-21. doi: 10.1159/000173420. Epub 2008 Dec 17. Oncology. 2008. PMID: 19092268

5

Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.

Kim W, Yoon JH, Kim JR, Jang IJ, Bang YJ, Kim YJ, Lee HS. Kim W, et al. Among authors: lee hs. Cancer Chemother Pharmacol. 2009 Aug;64(3):497-507. doi: 10.1007/s00280-008-0897-1. Epub 2008 Dec 20. Cancer Chemother Pharmacol. 2009. PMID: 19096848

6

Heat shock protein 90 inhibitor induces apoptosis and attenuates activation of hepatic stellate cells.

Myung SJ, Yoon JH, Kim BH, Lee JH, Jung EU, Lee HS. Myung SJ, et al. Among authors: lee hs, lee jh. J Pharmacol Exp Ther. 2009 Jul;330(1):276-82. doi: 10.1124/jpet.109.151860. Epub 2009 Mar 27. J Pharmacol Exp Ther. 2009. PMID: 19329756

7

Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells.

Lee JH, Yoon JH, Yu SJ, Chung GE, Jung EU, Kim HY, Kim BH, Choi DH, Myung SJ, Kim YJ, Kim CY, Lee HS. Lee JH, et al. Among authors: lee hs. Cancer Lett. 2010 Sep 28;295(2):229-35. doi: 10.1016/j.canlet.2010.03.005. Epub 2010 Mar 28. Cancer Lett. 2010. PMID: 20350780

8

Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells.

Jung EU, Yoon JH, Lee YJ, Lee JH, Kim BH, Yu SJ, Myung SJ, Kim YJ, Lee HS. Jung EU, et al. Among authors: lee hs, lee jh, lee yj. Cancer Lett. 2010 Dec 1;298(1):9-15. doi: 10.1016/j.canlet.2010.05.020. Epub 2010 Jun 22. Cancer Lett. 2010. PMID: 20573444

9

Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis.

Yu SJ, Yoon JH, Lee JH, Myung SJ, Jang ES, Kwak MS, Cho EJ, Jang JJ, Kim YJ, Lee HS. Yu SJ, et al. Among authors: lee hs, lee jh. Acta Pharmacol Sin. 2011 Jul;32(7):912-20. doi: 10.1038/aps.2011.24. Epub 2011 Jun 13. Acta Pharmacol Sin. 2011. PMID: 21666701 Free PMC article.

10

Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition.

Yu SJ, Yoon JH, Yang JI, Cho EJ, Kwak MS, Jang ES, Lee JH, Kim YJ, Lee HS, Kim CY. Yu SJ, et al. Among authors: lee hs, lee jh. J Bioenerg Biomembr. 2012 Feb;44(1):101-15. doi: 10.1007/s10863-012-9416-5. Epub 2012 Feb 15. J Bioenerg Biomembr. 2012. PMID: 22350012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,488 results

Search Page

Filters